René Milcent

5-[4-(Benzyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one derivatives and related analogs: new reversible, highly potent, and selective monoamine oxidase type B inhibitors

Fathi Mazouz, Salah Gueddari, Claude Burstein et al. · Journal of Medicinal Chemistry · 1993 · 75 citations · Full text

Synthesis of new derivatives of 4‐amino‐2,4‐dihydro‐1,2,4‐triazol‐3‐one as potential antibacterial agents

Frédérique Malbec, René Milcent, P. VICART et al. · Journal of Heterocyclic Chemistry · 1984 · 64 citations

Bioorganic Chemistry, Engineering, New Derivatives +17

Dramatic Species Differences in the Susceptibility of Monoamine Oxidase B to a Group of Powerful Inhibitors

M. Krueger, Fathi Mazouz, Rona R. Ramsay et al. · Biochemical and Biophysical Research Communications · 1995 · 45 citations

Monoamine Oxidase B, Biochemistry, Medicine +10

5-Aryl-1,3,4-oxadiazol-2(3H)-one derivatives and sulfur analogues as new selective and competitive monoamine oxidase type B inhibitors

Fathi Mazouz, Luc Lebreton, René Milcent et al. · European Journal of Medicinal Chemistry · 1990 · 44 citations

Medicinal Chemistry, Sulfur Analogues, Biochemistry +11

New general synthesis of tetrahydro‐1,2,4,5‐tetrazin‐3(2<i>H</i>)‐one derivatives and stable 3,4‐dihydro‐3‐oxo‐1,2,4,5‐tetrazin‐1(2<i>H</i>)‐yl radical derivatives

René Milcent, Géo Barbier, Sylvie Capelle et al. · Journal of Heterocyclic Chemistry · 1994 · 43 citations

Engineering, Derivatives 3, Organic Chemistry +17